Epizyme, Inc. vs. GlaxoSmithKline LLC
Explore the PTAB proceeding IPR2020-01577 filed by Epizyme, Inc. on 2020-09-04. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2020-01577
Filing Date
2020-09-04
Accorded Filing Date
2020-09-18
Institution Decision Date
2021-03-05
Last Modified Date
2022-09-01
Proceeding Type
IPR
Termination Date
2021-09-14
Trial Status
Terminated-Settled
Parties & Counsel
Petitioner
Epizyme, Inc.
Represented By
Edward GatesPatent Owner / Respondent
GlaxoSmithKline LLC
Represented By
Dorothy WhelanPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Terminated-Settled
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 36689 | Nora Stein | +1 484-949-5801 |
| 45582 | John Young | +1 919-483-8160 |
| 45941 | Eric Kron | +1 919-483-8961 |
| 48708 | Joseph Schuller | +1 202-617-7187 |
| 51491 | Alice Bradney | +1 919-450-8851 |
| 53619 | Thomas Smith | +1 610-270-5408 |
| 54121 | Kelly Gauger | +1 732-434-8267 |
| 55702 | Laura Vogel | +1 617-274-2994 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 10,478,426 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 2012616477 | US Continuation / Sibling | View Official Patent → |
| ๐ PCT International (WIPO) | WO 2013173441 A2 | PCT World Application | View Official Patent → |
| ๐บ๐ธ United States | US 2014144008 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 9,956,210 B2 | US Continuation / Sibling | View Official Patent → |
Epizyme, Inc. v. GlaxoSmithKline LLC